Research Articles | Page 7 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes Apr 2021 Hematology/oncology clinics of North America myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype Jul 2020 Blood acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Jan 2019 Leukemia myelodysplastic syndromes (MDS)
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases May 2015 J Hematol Oncol myelodysplastic syndromes (MDS)
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes Nov 2016 N Engl J Med myelodysplastic syndromes (MDS)
Towards a Conceptualization of Measurable Residual Disease in Myelodysplastic Syndromes Jun 2023 Blood Advances myelodysplastic syndromes (MDS)
Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes Mar 2014 Expert Rev Anticancer Ther myelodysplastic syndromes (MDS)
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria Jan 2018 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms Mar 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia Jun 2020 Haematologica acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Share with addtoany.com.